|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 38/08 | (2013.01) | ||
| A61K 38/08 | (2019.01) | ||
| C07K 14/5759 | (2013.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 9/0048 | (2013.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61K 38/13 | (2013.01) | ||
| C07K 7/06 | (2006.01) | ||
| C07K 14/47 | (2013.01) | ||
| A61K 38/22 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| C07K 7/06 | (2013.01) | ||
| A61K 31/4725 | (2013.01) |
| (11) | Patento numeris | 3288577 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16789840.2 |
| Europos patento paraiškos padavimo data | 2016-04-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-10-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/030142 |
| Data | 2016-04-29 |
| (87) | Numeris | WO 2016/179007 |
| Data | 2016-11-10 |
| (30) | Numeris | Data | Šalis |
| 201562156127 P | 2015-05-01 | US |
| (72) |
HSU, Henry , US
|
| (73) |
Allysta Pharmaceuticals, Inc. ,
19 Davis Drive, Belmont, California 94002,
US
|
| (54) | ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS |
| ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS |